Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Latanoprost's effectiveness for hair growth is not confirmed but shows promise, needing more research.

A woman got unwanted hair growth on her face from using bimatoprost eyedrops for glaucoma.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Using travoprost for glaucoma may cause extra hair growth and darker skin around the eyes, but these effects can reverse after stopping the drug.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

Latanoprost eye drops caused excessive cheek hair growth and eyelash whitening in a woman.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

PGF_2α receptors in human eyelids are found in specific parts of hair follicles, explaining eyelash changes with glaucoma treatment.

Travoprost can help eyelash growth but may cause darkening around the eyes.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Two children grew extra hair from taking omeprazole, which went away after they stopped the medication.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

PGD2 stops hair growth and is higher in bald men with AGA.